Hostname: page-component-76d6cb85b7-jhrpq Total loading time: 0 Render date: 2026-07-11T02:47:33.544Z Has data issue: false hasContentIssue false

The epidemiology and global burden of autism spectrum disorders

Published online by Cambridge University Press:  01 August 2014

A. J. Baxter*
Affiliation:
School of Population Health, University of Queensland, Herston, Australia Queensland Centre for Mental Health Research, Wacol, Australia
T. S. Brugha
Affiliation:
Department of Health Sciences, University of Leicester, Leicester General Hospital, UK
H. E. Erskine
Affiliation:
School of Population Health, University of Queensland, Herston, Australia Queensland Centre for Mental Health Research, Wacol, Australia
R. W. Scheurer
Affiliation:
Queensland Centre for Mental Health Research, Wacol, Australia
T. Vos
Affiliation:
School of Population Health, University of Queensland, Herston, Australia Institute for Health Metrics and Evaluation, University of Washington, Seattle, WA, USA
J. G. Scott
Affiliation:
Queensland Centre for Mental Health Research, Wacol, Australia University of Queensland Centre for Clinical Research, Herston, Australia Royal Brisbane and Women's Hospital, Herston, Australia
*
* Address for correspondence: A. J. Baxter, M.P.H., Queensland Centre for Mental Health Research, University of Queensland, Brisbane, QLD 4074, Australia. (Email: amanda_baxter@qcmhr.uq.edu.au)

Abstract

Background

Autism spectrum disorders (ASDs) are persistent disabling neurodevelopmental disorders clinically evident from early childhood. For the first time, the burden of ASDs has been estimated for the Global Burden of Disease Study 2010 (GBD 2010). The aims of this study were to develop global and regional prevalence models and estimate the global burden of disease of ASDs.

Method

A systematic review was conducted for epidemiological data (prevalence, incidence, remission and mortality risk) of autistic disorder and other ASDs. Data were pooled using a Bayesian meta-regression approach while adjusting for between-study variance to derive prevalence models. Burden was calculated in terms of years lived with disability (YLDs) and disability-adjusted life-years (DALYs), which are reported here by world region for 1990 and 2010.

Results

In 2010 there were an estimated 52 million cases of ASDs, equating to a prevalence of 7.6 per 1000 or one in 132 persons. After accounting for methodological variations, there was no clear evidence of a change in prevalence for autistic disorder or other ASDs between 1990 and 2010. Worldwide, there was little regional variation in the prevalence of ASDs. Globally, autistic disorders accounted for more than 58 DALYs per 100 000 population and other ASDs accounted for 53 DALYs per 100 000.

Conclusions

ASDs account for substantial health loss across the lifespan. Understanding the burden of ASDs is essential for effective policy making. An accurate epidemiological description of ASDs is needed to inform public health policy and to plan for education, housing and financial support services.

Information

Type
Original Articles
Copyright
Copyright © Cambridge University Press 2014 

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

Article purchase

Temporarily unavailable

Supplementary material: File

Baxter Supplementary Material

Appendix

Download Baxter Supplementary Material(File)
File 267.8 KB